UBE2T helps repair damage in DNA, the instruction code inside your cells. The protein made by the UBE2T gene helps your cells fix everyday DNA wear so blood-forming cells and other tissues can keep working normally. If both copies carry harmful variants, this repair process may fail, which can cause a form of Fanconi anemia with low blood counts, growth or birth differences, and a higher chance of some cancers. UBE2T is mainly known in medicine rather than popular culture.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or manage processes throughout the body. In some genes, those instructions are for producing proteins, which are the parts of cells that do the work. Other genes mainly guide when certain processes happen, where they happen, and how active they are. Taken together, genes influence how the body develops and works, and they can shape how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
UBE2TGene function
What if the gene works
The UBE2T gene helps cells repair damaged DNA, especially a type of damage that can block normal DNA copying. This supports healthy cell division and helps protect tissues such as the bone marrow.
Risk
What if the gene does not work
More disruptive variants in the UBE2T gene can cause Fanconi anemia, with bone marrow failure, birth differences, and higher cancer risk. Milder variants may leave some activity, which can affect when features appear and how severe they are.
Treatment
What does that mean for your treatment
For people with a pathogenic variant in the UBE2T gene, no UBE2T-specific treatment or drug choice is currently established in clinical guidelines. In research, the UBE2T gene is being studied mainly as a possible cancer biomarker and drug target because increased activity has been linked to several tumors.
Conditions associated with UBE2T
Gene function
What if the gene works
Your cells use the UBE2T gene to help protect DNA during normal growth and renewal. Its protein is part of a tagging system that helps repair work happen in the right order. This is central to how the UBE2T gene helps repair DNA damage during everyday cell life.
The UBE2T gene helps attach ubiquitin (a small protein tag) to selected repair proteins. This tag changes how those proteins behave so DNA repair steps can start at the right time.
A key job of UBE2T is turning on an important DNA repair pathway used when both DNA strands are linked together by damage. It works with partner proteins so the repair team gathers at the right spot.
By supporting careful DNA repair while cells copy their genetic material, the UBE2T gene helps keep the genome stable. This steady upkeep supports normal cell growth and routine tissue renewal.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help account for normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the UBE2T gene can alter protein shape, stability, or activity, weakening a DNA repair step that depends on adding ubiquitin (a small cell tag) to FANCD2. This is how variants in the UBE2T gene affect DNA repair at the cell level. Milder variants may leave some activity, while more severe variants can greatly reduce this pathway and are linked to earlier or more pronounced Fanconi anemia features.
How variants are linked to conditions
Pathogenic variants in the UBE2T gene cause a rare inherited form of Fanconi anemia, often called Fanconi anemia complementation group T. UBE2T gene variants and Fanconi anemia are linked through changes in both copies of the gene, which can confirm the diagnosis. People with this condition may have low blood counts, bone marrow failure, differences present from birth, and a higher chance of certain cancers over time.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal part of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences are involved. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For UBE2T, risk is mainly changed by inheritance: it is much higher when both parents carry a harmful UBE2T change, and it can also be higher in families where relatives have children together. If someone inherits two harmful UBE2T changes, there is not enough evidence to say lifestyle changes lower the chance of having the condition.
Inheritance of UBE2T variants
For families asking about the inheritance of the UBE2T gene variants, the well-established pattern is autosomal recessive. This means a person usually inherits one altered copy of the UBE2T gene from each parent. Parents who each carry one variant are often unaffected themselves, but with each pregnancy they have a 25% chance of having a child with both altered copies, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two working copies. This pattern applies to the recognized UBE2T-related condition in human genetics.
What does my UBE2T result mean for my family?
For families with a disease-causing UBE2T result linked to Fanconi anemia, close relatives may also carry the same gene change. Brothers and sisters could be affected or be carriers, and parents are usually carriers when a child has this condition. Other relatives may also want to learn whether the change runs in the family, especially if there is a history of bone marrow problems, unusual infections, or certain cancers at a young age.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the UBE2T gene, a lab can analyze DNA from a blood sample, saliva, or cheek swab using genetic testing for UBE2T variants. The test reads the gene's sequence and compares any changes with known patterns to report whether a variant is present and how it is usually classified.
When should I consider getting a genetic test?
Testing for changes in the UBE2T gene may be considered if you or your child has signs of Fanconi anemia, such as low blood counts, bone marrow failure, birth differences, poor growth, or chromosome breakage on lab tests. It can also help if this condition runs in the family or a relative carries a UBE2T change.
A genetic result is only one part of your health story
A genetic finding can provide meaningful information, but how much it reveals depends on the condition and the specific type of variant. Lifestyle, environment, age, and medical history, among other factors, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results may also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body breaks down, transports, or responds to a drug, and these differences are common.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and drugs, it helps explain why the same treatment may not work the same way for everyone. With many medications, genes can influence both how strongly a medicine works and how the body handles it. Understanding this can support treatment choices that are better informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the UBE2T gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
UBE2T entered the genetics literature through research on inherited bone marrow failure, especially Fanconi anemia. In the 2000s, scientists studying this condition mapped key repair genes step by step, and UBE2T became recognized as an important part of that pathway. From these first observations, research expanded steadily. A major milestone came in 2015, when people with Fanconi anemia were found to carry pathogenic variants in the UBE2T gene, establishing it as FANCT, a named Fanconi anemia subtype. That discovery connected earlier laboratory findings with a clear human diagnosis. Since then, UBE2T has remained mainly a gene of specialist interest in DNA repair and rare inherited conditions, rather than a gene shaped by broad public attention.